scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0378-4347(01)00056-1 |
P698 | PubMed publication ID | 11393724 |
P50 | author | Adrián Llerena | Q56419301 |
P2093 | author name string | Roland Berecz | |
Alfredo de la Rubia | |||
A Llerena | |||
A de la Rubia | |||
M J Norberto | |||
R Berecz | |||
Marı́a Jesús Norberto | |||
P2860 | cites work | Automated determination of clozapine and major metabolites in serum and urine | Q73602213 |
Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection | Q77392437 | ||
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine | Q34048732 | ||
Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms | Q34345969 | ||
Clinical profile of clozapine: adverse reactions and agranulocytosis | Q35531493 | ||
Update on the clinical efficacy and side effects of clozapine | Q37281165 | ||
Pharmacokinetics and pharmacodynamics of clozapine | Q40886861 | ||
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test | Q43201721 | ||
Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine | Q56080400 | ||
Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient | Q57585976 | ||
Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers | Q57586060 | ||
Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection | Q67931630 | ||
Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection | Q67982487 | ||
Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection | Q70624976 | ||
Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients | Q71295917 | ||
Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma | Q71840605 | ||
Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection | Q73230442 | ||
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics | Q73420679 | ||
P4510 | describes a project that uses | high-performance liquid chromatography | Q381233 |
P433 | issue | 1-2 | |
P921 | main subject | high-performance liquid chromatography | Q381233 |
P304 | page(s) | 349-354 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | Journal of Chromatography B: Biomedical Sciences and Applications | Q24039131 |
P1476 | title | Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection | |
P478 | volume | 755 |
Q44249382 | Determination of clozapine, and its metabolites, N-desmethylclozapine and clozapine N-oxide in dog plasma using high-performance liquid chromatography |
Q44228212 | Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients. |
Q44060212 | Direct-injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N-desmethylclozapine in human plasma |
Q83908248 | Dispersive liquid-liquid microextraction combined with high-performance liquid chromatography for the determination of clozapine and chlorpromazine in urine |
Q43238270 | Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl clozapine (norclozapine) in human serum |
Q44109171 | Recovery, enrichment and selectivity in liquid-phase microextraction comparison with conventional liquid-liquid extraction |
Search more.